Total Payments
$1,221
2024 Payments
$216.78
Companies
20
Transactions
52
Medicare Patients
2,904
Medicare Billing
$315,525
Payment Breakdown by Category
Food & Beverage$1,186 (97.1%)
Other$18.69 (1.5%)
Education$16.74 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,186 | 50 | 97.1% |
| Entertainment | $18.69 | 1 | 1.5% |
| Education | $16.74 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $284.16 | 11 | $0 (2022) |
| Gilead Sciences, Inc. | $277.02 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $94.56 | 6 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $91.07 | 1 | $0 (2018) |
| PFIZER INC. | $56.25 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $54.71 | 4 | $0 (2019) |
| RedHill Biopharma Inc. | $48.46 | 3 | $0 (2023) |
| Allergan Inc. | $45.74 | 3 | $0 (2019) |
| Medtronic MiniMed, Inc. | $36.75 | 2 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $29.50 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $216.78 | 4 | Gilead Sciences, Inc. ($150.00) |
| 2023 | $141.03 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($41.93) |
| 2022 | $78.99 | 5 | ABBVIE INC. ($41.94) |
| 2020 | $32.00 | 2 | AbbVie Inc. ($18.02) |
| 2019 | $138.16 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($23.43) |
| 2018 | $326.14 | 12 | Janssen Scientific Affairs, LLC ($91.07) |
| 2017 | $287.85 | 13 | AbbVie, Inc. ($190.55) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: INFLAM | ||||||
| 10/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Gastroenterology | ||||||
| 04/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Gastroenterology | ||||||
| 09/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Gastroenterology | ||||||
| 06/07/2023 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/17/2023 | RedHill Biopharma Inc. | — | Food and Beverage | Cash or cash equivalent | $15.66 | General |
| 02/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Gastroenterology | ||||||
| 01/31/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.48 | General |
| Category: Neuroscience | ||||||
| 01/17/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 01/11/2023 | RedHill Biopharma Inc. | Talicia (Drug), Movantik, Aemcolo | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Antibiotic | ||||||
| 11/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Gastroenterology | ||||||
| 10/11/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/16/2022 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Antibiotic | ||||||
| 04/25/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: VIROLOGY | ||||||
| 01/07/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.98 | General |
| 11/19/2019 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 10/25/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2019 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Immunology | ||||||
| 08/12/2019 | Mauna Kea Technologies, Inc. | — | Entertainment | Cash or cash equivalent | $18.69 | General |
| Category: Cellvizio | ||||||
| 07/24/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Durable Pump | ||||||
| 07/22/2019 | PFIZER INC. | XELJANZ (Drug) | Education | In-kind items and services | $16.74 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 649 | 773 | $338,930 | $70,768 |
| 2022 | 10 | 691 | 805 | $346,015 | $73,214 |
| 2021 | 11 | 799 | 1,006 | $457,020 | $99,077 |
| 2020 | 10 | 765 | 914 | $358,285 | $72,466 |
Total Patients
2,904
Total Services
3,498
Medicare Billing
$315,525
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 219 | 311 | $41,985 | $19,348 | 46.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 63 | 63 | $94,500 | $12,416 | 13.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $24,790 | $7,861 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 78 | $16,380 | $6,654 | 40.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 39 | 40 | $38,000 | $6,569 | 17.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 65 | 68 | $49,300 | $6,173 | 12.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $17,775 | $4,689 | 26.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $15,200 | $2,837 | 18.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $11,400 | $1,509 | 13.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $19,800 | $1,436 | 7.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $9,800 | $1,278 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 213 | 298 | $62,580 | $23,434 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 139 | 158 | $21,330 | $10,272 | 48.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 55 | 57 | $85,500 | $9,988 | 11.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 76 | 84 | $60,900 | $7,445 | 12.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $23,155 | $7,094 | 30.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 27 | 27 | $25,650 | $4,238 | 16.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 58 | 58 | $13,050 | $3,278 | 25.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 18 | 18 | $17,100 | $3,179 | 18.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $18,050 | $2,469 | 13.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $18,700 | $1,816 | 9.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 304 | 496 | $104,160 | $43,787 | 42.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 73 | 75 | $112,500 | $14,216 | 12.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 106 | 106 | $35,510 | $12,490 | 35.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 90 | 94 | $68,150 | $7,289 | 10.7% |
About Dr. Pratyusha Parava, M.D
Dr. Pratyusha Parava, M.D is a Gastroenterology healthcare provider based in Midland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2010. The National Provider Identifier (NPI) number assigned to this provider is 1144523549.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pratyusha Parava, M.D has received a total of $1,221 in payments from pharmaceutical and medical device companies, with $216.78 received in 2024. These payments were reported across 52 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,186).
As a Medicare-enrolled provider, Parava has provided services to 2,904 Medicare beneficiaries, totaling 3,498 services with total Medicare billing of $315,525. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Midland, TX
- Active Since 12/07/2010
- Last Updated 03/26/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1144523549
Products in Payments
- Livdelzi (Drug) $150.00
- STELARA (Biological) $134.34
- XIFAXAN (Drug) $94.56
- Epclusa (Drug) $74.97
- Viekira (Drug) $45.95
- XELJANZ (Drug) $42.53
- Minimed 670G System (Device) $36.75
- Mavyret (Drug) $33.65
- Talicia (Drug) $32.80
- VOQUEZNA (Drug) $29.50
- VIBERZI (Drug) $29.13
- Humira (Biological) $27.66
- OCALIVA (Drug) $27.41
- TOUJEO (Drug) $24.70
- CREON (Drug) $24.07
- ZEPOSIA (Drug) $22.48
- IBSRELA (Drug) $20.09
- MAVYRET (Drug) $18.02
- RINVOQ (Biological) $17.87
- Vascepa (Drug) $17.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Midland
Dr. Govind Patel, M.d, M.D
Gastroenterology — Payments: $74,476
Gastroenterology $74,476
Todd Holtz, Md, MD
Gastroenterology — Payments: $6,061
Gastroenterology $6,061
Karen Huang, D.o, D.O
Gastroenterology — Payments: $5,319
Gastroenterology $5,319
Christina Murphy, Do, DO
Gastroenterology — Payments: $4,372
Gastroenterology $4,372
Ernest Ofori-Darko, Md, MD
Gastroenterology — Payments: $4,351
Gastroenterology $4,351
Dr. Mrunal Patel, M.d, M.D
Gastroenterology — Payments: $2,491
Gastroenterology $2,491